The president of the Vaccine Strategy Steering Committee, Alain Fischer, had indicated a preference for vaccinating caregivers with RNA-type vaccines in Moselle, a department where the variant of the coronavirus first identified in South Africa is actively circulating.
Invited Thursday by Sonia Mabrouk on Europe 1, the pediatrician and professor of immunology explained that it was simply a matter of saving time and that the AstraZeneca vaccine was "not a second-rate vaccine".
Guest (s): Alain Fischer, pediatrician, professor of immunology and president of the Vaccine Strategy Orientation Council